Screening doesn’t cut breast cancer deaths

London, March 24 (ANI): A Danish study has found that screening women for breast cancer doesn’t reduce the number of deaths from the disease, contrary to earlier findings.

A 2005 study suggested that screening had reduced breast cancer deaths by 25 percent in Copenhagen.

But researchers from the Nordic Cochrane Centre in Copenhagen, together with scientist from Folkehelseinstituttet in Oslo, identified important problems in this study and decided to undertake a more comprehensive analysis of the data.

They compared annual changes in breast cancer deaths in two Danish regions offering publicly organised screening programmes (Copenhagen and Funen county) with non-screened regions across the rest of Denmark.

Their analysis covered 10 years after screening could have had an effect on breast cancer mortality. For comparison, they also looked at the 10-year period before screening was introduced.

Data for each area were divided into three age bands. Women aged 55-74 years, who could benefit from screening, and women aged 35-55 years and 75-84 years, who were largely unaffected by screening.

They found that in women who could benefit from screening (55-74 years) breast cancer mortality declined by 1 percent per year in the screened areas and by 2 percent per year in the non-screened areas.

In women too young to benefit from screening (35-54 years), breast cancer mortality declined by 5 percent per year in the screened areas and by 6 percent per year in the non-screened areas during the same period.

For the older age groups (75-84 years), there was little change over time both in screened and non-screened areas.

“We were unable to find an effect of the Danish screening programme on breast cancer mortality. The reductions in breast cancer mortality we observed in screening regions were similar or less than those in non-screened areas and in younger age groups, and are more likely explained by changes in risk factors and improved treatment than by screening mammography,” the authors said.

“Our results are similar to what has been observed in other countries with nationally organised programmes. We believe it is time to question whether screening has delivered the promised effect on breast cancer mortality,” they added.

The study has been published on bmj.com. (ANI)

Breast-screening tests could ‘lead to unnecessary treatment,’ say experts

London, Feb 20 (ANI): Brit experts have cautioned that repeated breast screening tests could lead to unnecessary treatment while women remain ignorant of the risks.

Attacking the Government’s “unethical” leaflets for mammograms, they have said that these pieces of paper “do not come close to telling the truth.”

Twenty-three leading specialists have warned that breast cancer screening can lead to patients being given unnecessary surgery or chemotherapy.

They also claimed that in case cancers detected by the programme were left alone, many “might never appear in a woman’s natural lifespan.”

The warning comes in line with an analysis by the Nordic Cochrane Centre, which found that if 2,000 women were screened for ten years, 10 would be treated unnecessarily.

And a warning letter, signed by public health specialists, epidemiologists, oncologists, GPs and patient representatives, has been sent to the Times newspaper.

The criticism follows the warning by doctors that recent trends to reduce the physical marks caused by breast cancer surgery risk “losing some of the gain in survival” seen in the past decade.

And experts have cautioned that the stress on ensuring that breast surgery does not look unsightly may be at the risk of survival rates.

Monica Morrow, chief of the Breast Service at Memorial Sloan-Kettering Cancer Centre in New York, said that minimally invasive surgery might not be the best for patients.

“Failure to demand a rigorous evaluation of oncological outcomes as well as cosmetic ones runs the risk of losing some of the gains in survival seen in the past decade,” the Telegraph quoted her as writing in the British Medical Journal.

She added: “The local treatment of breast cancer is based on the results of numerous high quality clinical trials and is therefore a model for evidence based care. As we attempt to advance from good to great cosmetic outcomes it is important that we remember this.” (ANI)